Mistletoe

As an Integrative Cancer Therapy.

The liquid extract of the mistletoe plant has been used as an alternative method to treat cancer for close to a century. Mistletoe injections are currently among the most widely used non-conventional cancer treatments in Europe.

Mistletoe (Iscador/Iscar/Helixor) can be used in malignant and non-malignant tumors, for stimulation of bone marrow activity, and alongside conventional treatments to offset the side effects of chemotherapy/radiation such as nausea, vomiting, and lack of appetite. It can also be used to diminish tumor-related pain and reduce the risk of tumor recurrence. 

Mistletoe is administered subcutaneously (an injection) or intravenously (IV) at a frequency determined by Dr. Petteruti trained in mistletoe. Patients may experience headaches, fever, or a rash (These are positive signs!). Most patients experience a better quality of life as it stimulates the immune system. 

Call to set up your consultation to see if this therapy is right for you: 401-921-5934

Information provided by: www.believebig.org

 

Mistletoe articles:

Estko, M et al. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro. (2015) BMC Complementary and Alternative Medicine.

Cebovic T et al. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo. (2008). Phytotherapy Research.

Weissenstein U et al. Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro.

Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients.

Piao et al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian, and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. (2004)

Troger et al. Quality of Live of Patients with Advanced Pancreatic Cancer During Treatment With Mistletoe. (2014)

Troger et al. Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone.

Immunostimulatory properties of mistletoe extracts and their application in oncology

Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.

Summary of European Mistletoe in Cancer

Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Clinical trial information from John Hopkins can be found here: http://bit.ly/2nrc1Aq

 
*Mistletoe therapy is not FDA approved and is not insurance covered.